Publications by authors named "Assunta Melaccio"

Claim this Profile
I
Impact of Chemotherapy Dose Intensity on Pathological Complete Response in Pembrolizumab-Treated Early Triple-Negative Breast Cancer: A Real-World Multicenter Analysis.
Palma Fedele, Stefania Luigia Stucci, Matteo Landriscina, Maria Morritti, Francesco Giuliani, Assunta Melaccio

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 Inhibitors in Patients Aged 80 and Older with HR+/HER2- Metastatic Breast Cancer: A Real-World Multicenter Study.
Palma Fedele, Matteo Landriscina, Lucia Moraca, Antonio Cusmai, Antonio Gnoni, Assunta Melaccio

Cancers (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metronomic chemotherapy and breast cancer: a critical evaluation of its role in the new landscape of therapeutics.
Chiara Guarini, Anna Natalizia Santoro, Assunta Melaccio, Laura Lanotte, Gennaro Gadaleta-Caldarola

Expert Opin Drug Saf· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study.
Sonia Morè, Irene Federici, Alessandra Bossi, Serena Rupoli, Erika Morsia, Assunta Melaccio

Hemasphere· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic inhibition of isocitrate dehydrogenase mutations in glioma and cholangiocarcinoma: new insights and promises-a narrative review.
Valeria Internò, Assunta Melaccio, Pasquale Vitale, Roberta Spedaliere, Massimo Buonfantino

Chin Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study.
Palma Fedele, Matteo Landriscina, Lucia Moraca, Antonio Cusmai, Antonio Gnoni, Assunta Melaccio

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergizing Immunotherapy and Antibody-Drug Conjugates: New Horizons in Breast Cancer Therapy.
Antonello Pinto, Chiara Guarini, Marianna Giampaglia, Valeria Sanna, Assunta Melaccio

Pharmaceutics· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myeloma.
Ilaria Saltarella, Alexander Link, Aurelia Lamanuzzi, Christian Reichen, Joanna Robinson, Assunta Melaccio

Biomed Pharmacother· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Treatment Landscape of Elderly Patients with Hormone Receptor-Positive Her2 Negative Advanced Breast Cancer: Current Perspectives and Future Directions.
Carmelo Laface, Francesco Giuliani, Assunta Melaccio, Maria Nicla Pappagallo, Anna Natalizia Santoro

J Clin Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in pharmacotherapies that target the cell cycle for treatment of breast cancer: where are we at today?
Martina Perrone, Francesco Giuliani, Valeria Sanna, Stefania Bruno, Assunta Melaccio

Expert Opin Pharmacother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives.
Felicia Maria Maselli, Francesco Giuliani, Carmelo Laface, Martina Perrone, Assunta Melaccio

Curr Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications.
Aurelia Lamanuzzi, Ilaria Saltarella, Antonia Reale, Assunta Melaccio, Antonio Giovanni Solimando

Biomedicines· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance.
Assunta Melaccio, Antonia Reale, Ilaria Saltarella, Vanessa Desantis, Aurelia Lamanuzzi

J Clin Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs.
Ilaria Saltarella, Aurelia Lamanuzzi, Vanessa Desantis, Lucia Di Marzo, Assunta Melaccio

J Pathol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression.
Antonio G Solimando, Matteo C Da Vià, Patrizia Leone, Paola Borrelli, Giorgio A Croci, Assunta Melaccio

Haematologica· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease.
Vanessa Desantis, Antonio Giovanni Solimando, Ilaria Saltarella, Antonio Sacco, Viviana Giustini, Assunta Melaccio

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Therapeutic Role of Angiogenic Microenvironment in Thyroid Cancer.
Assunta Melaccio, Lucia Ilaria Sgaramella, Alessandro Pasculli, Giovanna Di Meo, Angela Gurrado

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombopoietin Promotes Angiogenesis and Disease Progression in Patients with Multiple Myeloma.
Aurelia Lamanuzzi, Ilaria Saltarella, Maria A Frassanito, Domenico Ribatti, Assunta Melaccio

Am J Pathol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?
Roberto Ria, Francesco Prete, Assunta Melaccio, Giovanna Di Meo, Ilaria Saltarella

Surgery· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study.
Sebastiano Cicco, Antonio Giovanni Solimando, Roberta Buono, Nicola Susca, Gianfranco Inglese, Assunta Melaccio

Life (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients.
Roberto Ria, Assunta Melaccio, Vito Racanelli, Angelo Vacca

J Clin Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance.
Vanessa Desantis, Ilaria Saltarella, Aurelia Lamanuzzi, Assunta Melaccio, Antonio Giovanni Solimando

Int J Mol Sci· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma.
Ilaria Saltarella, Vanessa Desantis, Assunta Melaccio, Antonio Giovanni Solimando, Aurelia Lamanuzzi

Cells· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment.
Antonio Giovanni Solimando, Matteo Claudio Da Vià, Sebastiano Cicco, Patrizia Leone, Giuseppe Di Lernia, Assunta Melaccio

J Clin Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma.
Barbara Castella, Assunta Melaccio, Myriam Foglietta, Chiara Riganti, Massimo Massaia

Front Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis